Continuous glucose monitoring in comorbid dementia and diabetes – The evidence so far

Ergin, Busra Donat, Gadsby-Davis, Kieran, Mattishent, Katharina, Dhatariya, Ketan, Garner, Nikki ORCID: https://orcid.org/0000-0002-3514-5950 and Hornberger, Michael ORCID: https://orcid.org/0000-0002-2214-3788 (2024) Continuous glucose monitoring in comorbid dementia and diabetes – The evidence so far. Journal of Diabetes Science and Technology. ISSN 1932-2968

[thumbnail of donat-ergin-et-al-2024-continuous-glucose-monitoring-in-comorbid-dementia-and-diabetes-the-evidence-so-far]
Preview
PDF (donat-ergin-et-al-2024-continuous-glucose-monitoring-in-comorbid-dementia-and-diabetes-the-evidence-so-far) - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (315kB) | Preview

Abstract

Background: Type 2 diabetes mellitus (T2DM) and dementia are two of the leading chronic diseases in aging and are known to influence each other’s disease progression. There is well-established evidence that T2DM increases the risk for cognitive decline and dementia. At the same time, people with cognitive changes or dementia can find it difficult to manage their diabetes, resulting in hyper- or hypoglycemic events which can exacerbate the dementia disease progression further. Monitoring of glucose variability is, therefore, of critical importance during aging and when people with T2DM develop dementia. The advent of continuous glucose monitoring (CGM) has allowed the monitoring of glucose variability in T2DM more closely. The CGM seems to be highly feasible and acceptable to use in older people with T2DM and has been shown to significantly reduce their hypoglycemic events, often resulting in falls. Less is known as to whether CGM can have a similar beneficial effect on people with T2DM who have cognitive impairment or dementia in community or hospital settings. Aims: The current perspective will explore how CGM has made an impact on T2DM management in older people and those with comorbid cognitive impairment or dementia. We will further explore opportunities and challenges of using CGM in comorbid T2DM and dementia in community and hospital settings.

Item Type: Article
Uncontrolled Keywords: alzheimer’s diseases,cgm device,continuous glucose monitoring,dementia,type 2 diabetes mellitus,bioengineering,internal medicine,biomedical engineering,endocrinology, diabetes and metabolism,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/1500/1502
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Faculty of Medicine and Health Sciences > School of Health Sciences
UEA Research Groups: Faculty of Science > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Groups > Health Promotion
Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine
Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health
Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging
Faculty of Medicine and Health Sciences > Research Groups > Mental Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 27 Nov 2024 10:47
Last Modified: 19 Jan 2025 00:59
URI: https://ueaeprints.uea.ac.uk/id/eprint/97785
DOI: 10.1177/19322968241301058

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item